<p>(A) LNCaP cells were treated with either 100 ng/ml NRG or 50 nM rapamycin (Rapa) for 24 h, in the presence or in the absence of 10 mM NAC. Whole cell lysates were prepared and subjected to an immunoblot analysis with anti-LC3, anti-phospho-S6K and anti-S6K antibodies. (B) Densitometric analysis of the results described in A is represented as fold induction of the control untreated cells (n = 3, means ± S.D). (C) Representative images of cell morphology following treatments with NRG and rapamycin are shown (Olympus, 20×magnification). (D) LNCaP cells were treated with either 100 ng/ml NRG, 50 nM rapamycin or both for 24 h. Whole cell lysates were prepared and subjected to an immunoblot analysis with anti-LC3 antibodies. This experiment wa...
<p><b>A</b>, Rapamycin induced LC3 modification in the H9C2 cells after OGD tested by Western blotti...
<p>(A) Immortalized Akt<sup>tg</sup> and rpS6<sup>P-/-</sup>;Akt<sup>tg</sup>, MEFs were either untr...
<p>HEK293T cells were treated with different concentrations of bortezomib and the levels of autophag...
<p>(A) To determine autophagic activity in 1 μM rapamycin- or 1 μM rapamycin and 10 mM 3MA-treated N...
<p>(A) LNCaP cells were treated with 100 ng/ml neuregulin (NRG) in the presence or in the absence of...
<p>(A) LNCaP cells stably expressing LC3-GFP were treated with 100 ng/ml NRG for 24 h or incubated w...
<p>(A) LNCaP cells were treated with 100 ng/ml NRG for 24 h with or without 20 µM SP600125. Whole ce...
<p>Here, cells treated with 200 nM rapamycin for 24 h were used as the treated control (CTL). Then,...
<p>A–B) Western-blot analysis for GAPDH and LC3 of protein lysates obtained from HeLa cells treated ...
<p>Here, cells without any treatment were used as the untreated control (CTL). All experiments were...
<p>(A) LNCaP cells were transfected with Beclin 1 sh-RNA (3 µg) or control scrambled sh-RNA (3 µg) a...
<p>(A) LNCaP cells were treated with 100 ng/ml NRG with or without 10 mM <i>N</i>-acetylcysteine (NA...
<p>(A) N2a-FK cells were co-treated with LY294002 (10 μM) or PD98059 (50 μM) along with rapamycin (1...
<p>(A) Immunoblot analysis of LC3 and HSP70. Cells were treated for 24 h with rapamycin (Rapa, 5–20 ...
(A-C) PBMCs from healthy controls (A), GD (B), and FD (C) were treated with the 10 nM rapamycin (RAP...
<p><b>A</b>, Rapamycin induced LC3 modification in the H9C2 cells after OGD tested by Western blotti...
<p>(A) Immortalized Akt<sup>tg</sup> and rpS6<sup>P-/-</sup>;Akt<sup>tg</sup>, MEFs were either untr...
<p>HEK293T cells were treated with different concentrations of bortezomib and the levels of autophag...
<p>(A) To determine autophagic activity in 1 μM rapamycin- or 1 μM rapamycin and 10 mM 3MA-treated N...
<p>(A) LNCaP cells were treated with 100 ng/ml neuregulin (NRG) in the presence or in the absence of...
<p>(A) LNCaP cells stably expressing LC3-GFP were treated with 100 ng/ml NRG for 24 h or incubated w...
<p>(A) LNCaP cells were treated with 100 ng/ml NRG for 24 h with or without 20 µM SP600125. Whole ce...
<p>Here, cells treated with 200 nM rapamycin for 24 h were used as the treated control (CTL). Then,...
<p>A–B) Western-blot analysis for GAPDH and LC3 of protein lysates obtained from HeLa cells treated ...
<p>Here, cells without any treatment were used as the untreated control (CTL). All experiments were...
<p>(A) LNCaP cells were transfected with Beclin 1 sh-RNA (3 µg) or control scrambled sh-RNA (3 µg) a...
<p>(A) LNCaP cells were treated with 100 ng/ml NRG with or without 10 mM <i>N</i>-acetylcysteine (NA...
<p>(A) N2a-FK cells were co-treated with LY294002 (10 μM) or PD98059 (50 μM) along with rapamycin (1...
<p>(A) Immunoblot analysis of LC3 and HSP70. Cells were treated for 24 h with rapamycin (Rapa, 5–20 ...
(A-C) PBMCs from healthy controls (A), GD (B), and FD (C) were treated with the 10 nM rapamycin (RAP...
<p><b>A</b>, Rapamycin induced LC3 modification in the H9C2 cells after OGD tested by Western blotti...
<p>(A) Immortalized Akt<sup>tg</sup> and rpS6<sup>P-/-</sup>;Akt<sup>tg</sup>, MEFs were either untr...
<p>HEK293T cells were treated with different concentrations of bortezomib and the levels of autophag...